Calcipotriol-plus–5-FU therapy activates immune pathways, offering long-lasting protection against squamous cell carcinoma by ...

A new study uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first to activate specific components of the ...

A new study by investigators from Mass General Brigham uncovers how a novel immunotherapy prevents squamous cell carcinoma, ...

Post-treatment evaluations showed that the immunotherapy eliminated 95% of pre-cancerous spots on subjects' faces.

Eighteen patients with qualifying precancerous skin lesions were enrolled. Participants applied a treatment of 0.0025% calcipotriol and 2.5% 5-FU to affected areas—including the face ...

It enrolled 18 subjects with qualifying pre-cancerous skin lesions. Subjects applied a ... to affected areas twice a day for six days. Post-treatment evaluations showed that the immunotherapy ...

have reported outcomes from a study of a new immunotherapy for skin cancer prevention. The therapy combines topical calcipotriol with 5-fluorouracil (5-FU) and has been shown to eliminate precancerous ...